Lyme disease

Textbook of Pediatric Rheumatology

Volumn , Issue , 2005, Pages 591-603

  Huppertz, Hans Iko ^a   Dressler, Frank ^b  

^a Childrens' Hospital   (Germany)

^b UNIVERSITY OF APPLIED SCIENCES AND ARTS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 41749107431     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-0246-8.50035-8     Document Type: Chapter

References (170)

1. Steere AC, Maliwista SE, Snydman DR, et al. Lyme arthritis. An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977, 20:7-17.
2. Burgdorfer W, Barbour AG, Hayes SF, et al. Lyme disease-a tick-borne spirochetosis?. Science 1982, 216:1317-1319.
3. Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med 1983, 308:733-740.
4. Stanek G, Strie F Lyme borreliosis. Lancet 2003, 362:1639-1647.
5. Steere AC Lyme disease. N Engl J Med 2001, 345:115-125.
6. Huppertz HI Childhood Lyme borreliosis in Europe. Eur J Pediatr 1990, 149:814-821.
7. Dressler F Lyme borreliosis in European children and adolescents. Clin Exp Rheumatol 1994, 12(Suppl 10):S49-S54.
8. Sigal LH Musculoskeletal manifestations of Lyme arthritis. Rheum Dis Clin North Am 1998, 24:323-351.
9. Buchwald A Ein Fall von diffuser idiopathischer Hautatrophie. Arch Dermatol Syph 1883, 10:553.
10. Afzelius A Verhandlungen der dermatologischen Gesellschaft zu Stockholm. Arch Dermatol Syph 1910, 101:404.
11. Garin C, Bujadoux A Paralysie par les tiques. J Med Lyon 1922, 71:765.
12. Bannwarth A Chronische lymphocytäre Meningitis, entzuündliche Polyneuritisund "Rheumatismus.". Arch Psychiatr Nervenkr 1941, 113:284.
13. Svartz N Penicillinbehandling vid dermatitis atrophicans Herxheimer. Nord Med 1946, 32:2783.
14. Binder E, Doepfmer R, Hornstein O Übertragung des Erythema chronicum migrans von Mensch zu Mensch in zwei Passagen. Klin Wochenschr 1955, 33:727.
15. Steere AC Lyme disease: a growing threat to urban populations. Proc Natl Acad Sci U S A 1994, 91:2378-2383.
16. Centers for Disease Control and Prevention (CDC) Lyme disease-United States, 1994. MMWR Morb Mortal Wkly Rep 1995, 44:459.
17. Centers for Disease Control and Prevention (CDC) Lyme disease-United States, 2000. MMWR Morb Mortal Wkly Rep 2002, 51:29.
18. Centers for Disease Control and Prevention (CDC) West Nile virus activity-United States, July 31-August 6, 2003. MMWR Morb Mortal Wkly Rep 2003, 52:741.
19. Berglund J, Eitrem R, Ornstein K, et al. An epidemiologic study of Lyme disease in Southern Sweden. N Engl J Med 1995, 333:1319.
20. Huppertz HI, Böhme M, Standaert SM, et al. Incidence of Lyme borreliosis in the Würzburg region of Germany. Eur J Clin Microbiol Infect Dis 1999, 18:697-703.
21. Gerber MA, Shapiro ED, Burke GS, et al. Lyme disease in children in southeastern Connecticut. N Engl J Med 1996, 335:1270-1274.
22. Huppertz HI, Karch H, Suschke HJ, et al. Lyme arthritis in European children and adolescents. Arthritis Rheum 1995, 38:361-368.
23. Steere AC, Dwyer E, Winchester R Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med 1990, 323:219-223.
24. Fish D Environmental risk and prevention of Lyme disease. Am J Med 1995, 98(Suppl 4A):2S-8S.
25. Subak S Effects of climate on variability in Lyme disease incidence in the Northeastern United States. Am J Epidemiol 2003, 157:531-538.
26. Cimperman J, Maraspin V, Lotric-Furlan S, et al. Concomitant infection with tick-borne encephalitis virus and Borrelia burgdorferi sensu lato in patients with acute meningitis or meningoencephalitis. Infection 1998, 26:160-164.
27. Krause PJ, Telford SR, Spielman A, et al. Concurrent Lyme disease and babesiosis: evidence for increased severity and duration of disease. JAMA 1996, 275:1657-1660.
28. Nadelman RB, Horowitz HW, Hsieh T, et al. Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Engl J Med 1997, 337:27-30.
29. Barbour AG, Hayes SF Biology of Borrelia species. Microbiol Rev 1986, 50:381-400.
30. Wienecke R, Neubert U, Volkenandt M Cross immunity among types of Borrelia burgdorferi. Lancet 1993, 342:435.
31. Nowakowski J, Schwartz I, Nadelman R, et al. Culture-confirmed infection and reinfection with Borrelia burgdorferi. Ann Intern Med 1997, 127:130-132.
32. Fraser CM, Casjens S, Huang WM, et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997, 390:580-586.
33. Anderson IF, Magnarelli LA: Avian and mammalian hosts for spirochete-infected ticks and insects in a Lyme disease focus in Connecticut. In Steere AC, Malawista AC, Craft JE, et al: First International Symposium on Lyme Disease, New Haven. Yale J Biol Med 57: 638, 1984.
34. Coburn J, Magoun L, Bodary SC, et al. Integrins alpha(v)-beta3 and alpha5betal mediate attachment of Lyme disease spirochetes to human cells. Infect Immun 1998, 66:1946-1952.
35. Coburn JC, Leong JM, Erban JK Integrin alpha lib-beta III mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets. Proc Natl Acad Sci U S A 1993, 90:7059-7063.
36. Ma Y, Sturrock A, Weis JJ Intracellular localization of Borrelia burgdorferi within human endothelial cells. Infect Immun 1991, 59:671-678.
37. Klempner M, Noring R, Rogers RA Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis 1993, 167:1074-1081.
38. Girschick HJ, Huppertz HI, Rüssmann H, et al. Intracellular persistence of Borrelia burgdorferi in human synovial cells. Rheumatol Int 1996, 16:125-132.
39. Yang L, Ma Y, Schoenfeld R, et al. Evidence of B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice. Infect Immun 1992, 60:3033-3041.
40. Yin Z, Braun J, Neure L, et al. T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum 1997, 40:69-79.
41. Gross DM, Steere AC, Huber BT T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J Immunol 1998, 160:1022-1028.
42. Busch DH, Jassoy C, Brinckmann U, et al. Detection of Borrelia burgdorferi-specific CD8+ cytotoxic T-cells in patients with Lyme arthritis. J Immunol 1996, 157:3534-3541.
43. Glatzel A, Entschladen F, Zollner TM, et al. The responsiveness of human V δ-γ-Tcells to Borrelia burgdorferi is largely restricted to synovial fluid cells from patients with Lyme arthritis. J Infect Dis 2002, 186:1043-1046.
44. Roessner K, Wolfe J, Shi C, et al. High expression of Fas ligand by synovial fluid-derived. γ cells in Lyme arthritis. J Immunol 2003, 170:2702-2710.
45. Miller LC, Isa S, Vannier E, et al. Live Borrelia burgdorferi preferentially activate interleukin-lbeta gene expression and protein synthesis over the interleukin-1 receptor antagonist. J Clin Invest 1992, 90:906-912.
46. Habicht GS, Katona LI, Benach JL Cytokines and the pathogenesis of neu-roborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6. J Infect Dis 1991, 164:568-574.
47. Defosse DL, Johnson RC In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi. Infect Immun 1992, 60:1109-1113.
48. Pohl-Koppe A, Balashov KE, Steere AC, et al. Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. J Immunol 1998, 160:1804-1810.
49. Weigelt W, Schneider T, Lange R Sequence homology between spirochaete flagellin and human myelin basic protein. Immunol Today 1992, 13:279-280.
50. Sigal LH Cross-reactivity between Borrelia burgdorferi flagellin and a human axonal 64000 molecular weight protein. J Infect Dis 1993, 167:1372-1378.
51. Kalish R, Leong JM, Steere AC Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun 1993, 61:2774-2779.
52. Kamradt T, Lengl-Janssen B, Strauss AF, et al. Dominant recognition of a Borrelia burgdorferi outer surface protein A peptide by T helper cells in patients with treatment-resistant Lyme arthritis. Infect Immun 1996, 64:1284-1289.
53. Gross DM, Forsthuber T, Tary-Lehmann M, et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998, 281:703-706.
54. Steere AC, Falk B, Drouin EE, et al. Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum 2003, 48:534-540.
55. Malane MS, Grant-Kels JM, Feder HM, et al. Diagnosis of Lyme disease based on dermatologic manifestations. Ann Intern Med 1991, 114:490-498.
56. Feder HM, Gerber MA, Krause PJ, et al. Early Lyme disease: a flu-like illness without erythema migrans. Pediatrics 1993, 91:456-459.
57. Pohl-Koppe A, Wilske B, Weiss M, et al. Borrelia lymphocytoma in childhood. Pediatr Infect Dis J 1998, 17:423-426.
58. Bfzonova I, Wollenberg A, Prinz JC Acrodermatitis chronica atrophicans affecting all four limbs in an 11-year-old girl. Br J Dermatol 2002, 147:375-378.
59. Christen HJ, Hanefeld F, Eiffert H, et al. Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis. Acta Paediatr 1993, 82(Suppl 386):1-75.
60. Hansen K, Lebech AM The clinical and epidemiologic profile of Lyme neuroborreliosis in Denmark 1985-1990. Brain 1992, 115:399-423.
61. Bloom BJ, Wyckoff PM, Meissner HC, et al. Neurocognitive abnormalities in children after classic manifestations of Lyme disease. Pediatr Infect Dis J 1998, 17:189-196.
62. Shapiro EE Guillain-Barrè syndrome in a child with serologic evidence of Borrelia burgdorferi infection. Pediatr Inf Dis J 1998, 17:264-265.
63. Horneff G, Huppertz H-l, Muller K, et al. Demonstration of Borrelia burgdorferi infection in a child with Guillain Barrè syndrome. Eur J Pediatr 1993, 152:810-812.
64. Kan L, Sood SK, Maytal J Pseudotumor cerebri in Lyme disease a case report and review of the literature. Pediatr Neurol 1998, 18:431-439.
65. Scott IU, Silva-Lepe A, Siatkowski RM Chiasmal optic neuritis in Lyme disease. Am J Ophthalmol 1997, 123:136-138.
66. Lock G, Berger G, Grobe H Neuroborreliosis: progressive encephalomyelitis with cerebral vasculitis. Monatsschr Kinderheilkd 1989, 137:101-104.
67. Oksi J, Kalimo H, Marttila RJ, et al. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain 1996, 119:2143-2154.
68. Chancellor MB, McGinnis DE, Shenot PJ, et al. Urinary dysfunction in Lyme disease. J Urol 1993, 149:26-30.
69. Huppertz HI, Karch H Die Lyme-Arthritis im Kindesalter: Monarthritis des Kniegelenks, klinisch nicht unterscheidbar von Monarthritiden unbekannter Ursache. Monatsschr Kinderheilkd 1991, 139:759-764.
70. Hammers-Berggren S, Andersson U, Stiernstedt G Borrelia arthritis in Swedish children: clinical manifestations in 10 children. Acta Paediatr 1992, 81:921-924.
71. Gerber MA, Zemel LS, Shapiro ED Lyme arthritis in children: clinical epidemiology and long-term outcomes. Pediatrics 1998, 102:905-908.
72. Reimers CD, de Koning J, Neubert U, et al. Borrelia burgdorferi myositis: report of eight patients. J Neurol 1993, 240:278-283.
73. Häupl T, Hahn G, Rittig M, et al. Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis. Arthritis Rheum 1993, 36:1621-1626.
74. Schnarr S, Wahl A, Jürgens-Saathoff B, et al. Nodular fasciitis, erythema migrans, and oligoarthritis: manifestation of Lyme borreliosis caused by Borrelia afzelii. Scand J Rheumatol 2002, 31:184-186.
75. Huppertz HI, Michels H Pattern of joint involvement in children with Lyme arthritis. Br J Rheumatol 1996, 35:1016-1018.
76. Huppertz HI, Münchmeier D, Lieb W Ocular manifestations in children and adolescents with Lyme arthritis. Br J Ophthalmol 1999, 83:1149-1152.
77. Marlovits S, Khanakah G, Striessnig G, et al. Emergence of Lyme arthritis after autologous chondrocyte transplantation. Arthritis Rheum 2004, 50:259-264.
78. Christofaro RL, Appel MH, Gelb RF, Williams CL Musculoskeletal manifestations of Lyme disease in children. J Pediatr Orthop 1987, 7:527-530.
79. Hoffmann JC, Stichtenoth DO, Zeidler H, et al. Lyme disease in a 74-year-old forest owner with symptoms of dermatomyositis. Arthritis Rheum 1995, 38:1157-1160.
80. Oksi J, Mertsola J, Reunanen M, et al. Subacute multiple-site osteomyelitis caused by Borrelia burgdorferi. Clin Infect Dis 1994, 19:891-896.
81. Sigal LH, Patella SJ Lyme arthritis as the incorrect diagnosis in pediatric and adolescent fibromyalgia. Pediatrics 1992, 90:523-528.
82. Cox J, Krajden M Cardiovascular manifestations of Lyme disease. Am Heart J 1991, 122:1449-1455.
83. Aaberg TM The expanding ophthalmologic spectrum of Lyme disease. Am J Ophthalmol 1989, 107:77-80.
84. Szer IS, Taylor E, Steere AC The long-term course of Lyme arthritis in children. N Engl J Med 1991, 325:159-163.
85. Edwards KS, Kanengiser S, Li KI, et al. Lyme disease presenting as hepatitis and jaundice in a child. Pediatr Infect Dis J 1990, 9:592-593.
86. Weber K, Bratzke HJ, Neubert U, et al. Borrelia burgdorferi in a newborn despite oral penicilline for Lyme borreliosis during pregnancy. Pediatr Infect Dis J 1988, 7:286-289.
87. Silver HM Lyme disease during pregnancy. Infect Dis Clin North Am 1997, 11:93-97.
88. Markowitz LE, Steere AC, Benach JL, et al. Lyme disease during pregnancy. JAMA 1986, 255:3394-3396.
89. Nadal D, Hunziker UA, Bucher HU, et al. Infants born to mothers with antibodies against Borrelia burgdorferi at delivery. Eur J Pediatr 1989, 148:426-427.
90. Johnston YE, Duray PH, Steere AC, et al. Spirochetes found in synovial microangiopathic lesions. Am J Pathol 1985, 118:26-34.
91. Snydman DR, Schenkein DP, Berardi VP, et al. Borrelia burgdorferi in joint fluid in chronic Lyme arthritis. Ann Intern Med 1986, 104:798-800.
92. De Koning J, Bosma RB, Hoogkamp-Korstanje JAA Demonstration of spirochaetes in patients with Lyme disease with a modified silver stain. J Med Microbiol 1987, 23:261-267.
93. Berger BW, Johnson RC, Kodner C, Coleman L Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J Clin Microbiol 1992, 30:359-361.
94. Stanek G, Klein J, Bittner R, Glogar D Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med 1990, 322:249-252.
95. Lardieri G, Salvi A, Camerini F Isolation of Borrelia burgdorferi from myocardium. Lancet 1993, 342:490.
96. Frey M, Jaulhac B, Piemont Y, et al. Detection of Borrelia burgdorferi DNA in muscle of patients with chronic myalgia related to Lyme disease. Am J Med 1998, 104:591-594.
97. Eppes SC, Nelson DK, Lewis LL, Klein JD Characterization of Lyme meningitis and comparison with viral meningitis in children. Pediatrics 1999, 103:1957-1960.
98. Golightly M Laboratory considerations in the diagnosis and management of Lyme borreliosis. Am J Clin Pathol 1993, 99:168-174.
99. American College of Physicians Guidelines for laboratory evaluation in the diagnosis of Lyme disease. Clinical guideline, part 1. Ann Intern Med 1997, 127:1106-1108.
100. Tugwell P, Dennis DT, Weinstein A, et al. Laboratory evaluation in the diagnosis of Lyme disease. Clinical guideline, part 2. Ann Intern Med 1997, 127:1109-1123.
101. Sigal LH Pitfalls in the diagnosis and management of Lyme disease. Arthritis Rheum 1998, 41:195-204.
102. Karlsson M, Hovind-Hougen K, Svenungsson B, et al. Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J Clin Microbiol 1990, 28:473-479.
103. Nocton JJ, Dressier F, Rutledge BJ, et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994, 330:229-234.
104. Carlson D, Hernandez J, Bloom BJ, et al. Lack of Borrelia burgdorferi DNA in synovial fluid samples from patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum 1999, 42:2705-2709.
105. Priem S, Rittig MG, Kamradt T, et al. An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme borreliosis. J Clin Microbiol 1997, 35:685-690.
106. Huppertz HI, Schmidt H, Karch H Detection of Borrelia burgdorferi by nested polymerase chain reaction in cerebrospinal fluid and urine of children with neuroborreliosis. Eur J Pediatr 1993, 152:414-417.
107. Karch H, Huppertz HI Repeated detection of Borrelia burgdorferi DNA in synovial fluid of a child with Lyme arthritis. Rheumatol Int 1993, 12:227-229.
108. Jaulhac B, Chary-Valckenaere I, Sibilia J, et al. Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis. Arthritis Rheum 1996, 39:736-745.
109. Priem S, Burmester GR, Kamradt T, et al. Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy. Ann Rheum Dis 1998, 57:118-121.
110. Karch H, Huppertz HI, Böhme M, et al. Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B.burgdorferi-specific antibodies. J Clin Microbiol 1994, 32:2312-2314.
111. Brown SL, Hansen SL, Langone JJ Role of serology in the diagnosis of Lyme disease. JAMA 1999, 282:62-66.
112. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995, 44:590-591.
113. Dressler F, Whalen JA, Reinhardt BN, et al. Western blotting in the serodi-agnosis of Lyme disease. J Infect Dis 1993, 167:392-400.
114. Engstrom SM, Shoop E, Johnson RC Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol 1995, 33:419-427.
115. Hauser U, Lehnert G, Lobentanzer R, et al. Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato. J Clin Microbiol 1997, 35:1433-1444.
116. Hauser U, Lehnert G, Wilkske B Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. J Clin Microbiol 1999, 37:2241-2247.
117. Bacon RM, Biggerstaff BJ, Schriefer ME, et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant vlsEl or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole cell lysates. J Infect Dis 2003, 187:1187-1199.
118. Heikkilä T, Huppertz HI, Seppälä I, et al. Recombinant or peptide antigens in the serology of Lyme arthritis in children. J Infect Dis 2003, 187:1888-1894.
119. Schulte-Spechtel U, Lehnert G, Liegl G, et al. Significant improvement of the recombinant Borrelia-specific immunoglobulin G immunoblot test by addition of vlsE and a DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis. J Clin Microbiol 2003, 41:1299-1303.
120. Levine D, Tilton RC, Parry MF, et al. False positive EBNA IgM and IgG antibody tests for infectious mononucleosis in children. Pediatrics 1994, 94:892-894.
121. Berardi VP, Weeks KE, Steere AC Serodiagnosis of early Lyme disease: analysis of IgM and IgG antibody responses by using an antibody-capture enzyme immunoassay. J Infect Dis 1988, 158:754-760.
122. Sood SK, Rubin LG, Blader ME, Ilowite NT Positive, serology for Lyme borreliosis in patients with juvenile rheumatoid arthritis in a Lyme borreliosis endemic area: analysis by immunoblot. J Rheumatol 1993, 20:739-741.
123. Saulsbury FT, Katzmann JA Prevalence of antibody to Borrelia burgdorferi in children with juvenile rheumatoid arthritis. J Rheumatol 1990, 17:1193-1194.
124. Weiss NL, Sadock VA, Sigel LH, et al. False positive seroreactivity to Borrelia burgdorferi in systemic lupus erythematosus: value of immunoblot analysis. Lupus 1995, 4:131-137.
125. Rose CD, Fawcett PT, Gibney KM, Doughty RA Residual serologic reactivity in children with resolved Lyme arthritis. J Rheumatol 1996, 23:367-369.
126. Nichol G, Dennis DT, Steere AC, et al. Test-treatment strategies for patients suspected of having Lyme disease: a cost-effectiveness analysis. Ann Intern Med 1998, 128:37-48.
127. Dressler F, Yoshinari NH, Steere AC The T-cell proliferative assay in the diagnosis of Lyme disease. Ann Intern Med 1991, 15:533-539.
128. Zoschke DC, Skemp AA, Defosse DL Lymphoproliferative responses to B. burgdorferi in Lyme disease. Ann Intern Med 1991, 114:285-289.
129. Huppertz HI, Mösbauer S, Busch DH, et al. Lymphoproliferative responses to Borrelia burgdorferi in the diagnosis of Lyme arthritis in children and adolescents. Eur J Pediatr 1996, 155:297-302.
130. Rutkowski S, Busch DH, Huppertz HI Lymphocyte proliferation assay in response to Borrelia burgdorferi in patients with Lyme arthritis: analysis of lymphocyte subsets. Rheumatol Int 1997, 17:151-158.
131. Huppertz HI, Bentas W, Haubitz I, et al. Diagnosis of pediatric Lyme arthritis using a clinical score. Eur J Pediatr 1998, 157:304-308.
132. Wharton M, Chorba TL, Vogt RL, et al. Case definitions for public health surveillance. MMWR Morb Mortal Wkly Rep 1990, 39:19.
133. Böhme M, Schweneke S, Fuchs E, et al. Screening of blood donors and recipients for Borrelia burgdorferi antibodies: no evidence of B. burgdorferi infection transmitted by transfusion. Infusionstherapie 1992, 19:204-207.
134. Zahid Qureshi M, New D, Zulqarni NJ, Nachman S Overdiagnosis and overtreatment of Lyme disease in children. Pediatr Infect Dis J 2002, 21:12-14.
135. Huppertz HI, Karch H, Heesemann J Diagnostic value of synovial fluid analysis in children with reactive arthritis. Rheumatol Int 1995, 15:167-170.
136. Kaiser R, Rauer S Analysis of the intrathecal immune response in neuroborreliosis to a sonicate antigen and three recombinant antigens of Borrelia burgdorferi sensu stricto. Eur J Clin Microbiol Infect Dis 1998, 17:159-166.
137. Dattwyler RJ, Volkman DJ, Conaty SM, et al. Amoxicillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis. Lancet 1990, 336:1404-1406.
138. Dattwyler RJ, Halperin JJ, Volkman DJ, et al. Treatment of late Lyme borreliosis randomised comparison of ceftriaxone and penicillin. Lancet 1988, 1:1191-1194.
139. Weber K, Preac-Mursic V, Wilske B, et al. A randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis. Infection 1990, 18:91-96.
140. Pfister HW, Preac-Mursic V, Wilske B, et al. Cefotaxime versus penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study. Arch Neurol 1989, 46:1190-1194.
141. Müllegger RR, Millner MM, Stanek G, Spork KD Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children-a Prospective study. Infection 1991, 19:279-283.
142. Massarotti EM, Luger SW, Rahn DW, et al. Treatment of early Lyme disease. Am J Med 1992, 92:396-403.
143. Nadelman RB, Luger SW, Frank E, et al. Comparison of cefuroxime and doxycycline in the treatment of early Lyme disease. Ann Intern Med 1992, 117:273-280.
144. Eppes SC, Childs JA Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease. Pediatrics 2002, 109:1173-1177.
145. Dattwyler RJ, Luft BJ, Kunkel MJ, et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med 1997, 337:289-294.
146. Hansen K, Hovmark A, Lebeque AM, et al. Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans. Acta Derm Venerol 1992, 72:297-300.
147. Weber K, Wilske B, Preac-Mursic V, Thurmayr R Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. Infection 1993, 21:367-372.
148. Strle F, Preac-Mursic V, Cimperman J, et al. Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiologic findings. Infection 1993, 21:83-88.
149. Luft BJ, Dattwyler RJ, Johnson RC, et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial. Ann Intern Med 1996, 124:785-791.
150. Steere AC, Levin RE, Molloy PJ, et al. Treatment of Lyme arthritis. Arthritis Rheum 1994, 37:878-888.
151. Bentas W, Karch H, Huppertz HI Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy. J Rheumatol 2000, 27:2025-2030.
152. Wormser GP, Ramanathan R, Nowakowski J, et al. Duration of antibiotic therapy for early Lyme disease. Ann Intern Med 2003, 138:697-704.
153. Thorstrand C, Belfrage E, Bennet R, et al. Successful treatment of neuroborreliosis with ten day regimens. Pediatr Infect Dis J 2002, 21:1142-1145.
154. Eckman MH, Steere AC, Kalish RA, Pauker SG Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis. N Engl J Med 1997, 337:357-363.
155. Gasser R, Wendelin I, Reisinger E, et al. Roxithromycin in the treatment of Lyme disease-update and perspectives. Infection 1995, 23(Suppl):S39-S43.
156. Schoen RT, Aversa JM, Rahn DW, et al. Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy. Arthritis Rheum 1991, 34:1056-1060.
157. American Academy of Pediatrics, Committee on Infectious Diseases Prevention of Lyme disease. Pediatrics 2000, 105:142-147.
158. Hayes EB, Piesman J How can we prevent Lyme disease?. N Engl J Med 2003, 348:2424-2430.
159. Crippa M, Rais O, Gern L Investigations on the mode and dynamics of transmission and infectivity of Borrelia burgdorferi sensu stricto and Borrelia afzelii in Ixodes ricinus ticks. Vector Borne Zoonotic Dis 2002, 2:3-9.
160. Nadelman RB, Nowakowski J, Fish D, et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 2001, 345:79-84.
161. Warshafsky S, Nowakowski J, Nadelman RB, et al. Efficacy of antibiotic prophylaxis for prevention of Lyme disease. J Gen Intern Med 1996, 11:329-333.
162. Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N Engl J Med 1998, 339:209-215.
163. Sigal LH, Zahradnik JM, Lavin P, et al. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. N Engl J Med 1998, 339:216-222.
164. Feder HM, Beran J, van Hoecke C, et al. lmmunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against Lyme disease in children. J Pediatr 1999, 135:575-579.
165. Recommendations for the use of Lyme disease vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999, 48:1-17. 21-25.
166. Adams WV, Rose CD, Eppes SC, Klein JD Cognitive effects of Lyme disease in children: a 4 year followup study. J Rheumatol 1999, 26:1190-1194.
167. Salazar JC, Gerber MA, Goff CW Long-term outcome of Lyme disease in children given early treatment. J Pediatr 1993, 122:591-593.
168. Seltzer EG, Gerber MA, Cartter M, et al. Long-term outcomes of persons with Lyme disease. JAMA 2000, 283:609-616.
169. Adams WV, Rose CD, Eppes SC, Klein JD Cognitive effects of Lyme disease in children. Pediatrics 1994, 94:185-189.
170. Shadick NA, Phillips CB, Logigian EL, et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med 1994, 121:560-567.